Arizona Health Sciences

Publications

Year of Publicationsort descending Title Faculty Association
2002 Diverse actions of ovarian steroids in the serotonin neural system. John M. Streicher, Ph.D.
2003 Characterization of reproductive steroid receptors and response to estrogen in a rat serotonergic cell line. John M. Streicher, Ph.D.
2004 Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. John M. Streicher, Ph.D.
2005 Serotonin-related gene expression in female monkeys with individual sensitivity to stress. John M. Streicher, Ph.D.
2008 The role of COX-2 in heart pathology. John M. Streicher, Ph.D.
2010 MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. John M. Streicher, Ph.D.
2010 Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. John M. Streicher, Ph.D.
2010 Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice. John M. Streicher, Ph.D.
2011 Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. Frank Porreca, PhD, Todd Vanderah, PhD
2011 Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD, Eva Varga, Ph.D.
2011 Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain. John M. Streicher, Ph.D.
2012 Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy. John M. Streicher, Ph.D.
2012 Activation of TRPA1 on dural afferents: a potential mechanism of headache pain. Frank Porreca, PhD, Todd Vanderah, PhD
2012 Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E₂ in the spinal cord. Josephine Lai , Ph.D., Tally Largent-Milnes, Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2012 Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist. Tally Largent-Milnes, Ph.D., William R. Roeske, MD, Todd Vanderah, PhD, Eva Varga, Ph.D.
2012 Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors. Frank Porreca, PhD, Todd Vanderah, PhD
2012 Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues. John M. Streicher, Ph.D.
2012 Mechanisms of Bv8-induced biphasic hyperalgesia: increased excitatory transmitter release and expression. Michael H. Ossipov, Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2012 Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation. Victor Hruby, Ph.D., Tally Largent-Milnes, Ph.D., Todd Vanderah, PhD, Eva Varga, Ph.D.
2013 Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism. Thomas P Davis, PhD, Patrick T Ronaldson, PhD, Todd Vanderah, PhD
2013 Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons. John M. Streicher, Ph.D.
2013 Cancer-induced bone pain: Mechanisms and models. Todd Vanderah, PhD
2013 Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. Patrick W Mantyh, Ph.D., Tally Largent-Milnes, Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2013 Development of functionally selective, small molecule agonists at kappa opioid receptors. John M. Streicher, Ph.D.
2013 Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain. Victor Hruby, Ph.D., Todd Vanderah, PhD

Pages